We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > portfolio

News List

Karolinska Development's portfolio company Modus Therapeutics has successfully dosed first cohort in phase 1 study of subcutaneously administered sevuparin firstwordpharma
February 24, 2019
Karolinska Development's portfolio company Modus Therapeutics announces today that the first cohort has been successfully dosed in its phase 1 study to explore the pharmacokinetics, safety and tolerability of subcutaneous sevuparin injections in healthy a
Piramal Enterprises to acquire portfolio of drugs Mallinckrodt financialexpress
February 07, 2017
The portfolio acquired includes Gablofen (baclofen), a severe spasticity management product, which is currently marketed in the US, and two pain management products, which are currently under development

Previous page 1 2 Next page